These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 18176119)

  • 1. Subcutaneous implantable venous access device erosion through the skin in patients treated with anti-vascular endothelial growth factor therapy: a case series.
    Almhanna K; Pelley RJ; Thomas Budd G; Davidson J; Moore HC
    Anticancer Drugs; 2008 Feb; 19(2):217-9. PubMed ID: 18176119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indwelling central venous access port insertion during bevacizumab-based therapy.
    Grenader T; Goldberg A; Verstandig A; Shavit L
    Anticancer Drugs; 2010 Aug; 21(7):704-7. PubMed ID: 20517148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin erosion over totally implanted vascular access devices in children.
    Bass J; Halton JM
    Semin Pediatr Surg; 2009 May; 18(2):84-6. PubMed ID: 19348996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wound healing and catheter thrombosis after implantable venous access device placement in 266 breast cancers treated with bevacizumab therapy.
    Kriegel I; Cottu PH; Fourchotte V; Sanchez S; Fromantin I; Kirov K; Guillaume A; Pelloquin A; Esteve M; Salmon RJ
    Anticancer Drugs; 2011 Nov; 22(10):1020-3. PubMed ID: 21970853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Implantable devices for central venous access in cancer patients. Our experience in 217 cases].
    Torramadé J; Hernández JL; Cienfuegos JA; Albiach M; Pardo F; Benito C; González J; Voltas J
    Med Clin (Barc); 1992 May; 98(19):731-3. PubMed ID: 1608278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dysfunctional central venous line.
    Azam F; Pwint T; Gupta A
    Neth J Med; 2010 Mar; 68(3):129-33. PubMed ID: 20308709
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignancies.
    Subramaniam A; Kim KH; Bryant SA; Kimball KJ; Huh WK; Straughn JM; Estes JM; Alvarez RD
    Gynecol Oncol; 2011 Oct; 123(1):54-7. PubMed ID: 21742372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complications associated with the placement of subcutaneous central venous access port devices: reasons for removal and complications observed].
    Danno K; Ohnishi T; Watanabe A; Ueda M; Yanagawa T; Kim C; Fujita S; Fujita J; Yoshida T; Tono T; Monden T; Imaoka S
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2404-6. PubMed ID: 23268092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis.
    Ghayyda SN; Roland D; Cade A
    J Cyst Fibros; 2008 Sep; 7(5):448-9. PubMed ID: 18455967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of implantable venous access devices (IVADs) in children with hemophilia.
    Perkins JL; Johnson VA; Osip JM; Christie BA; Nelson SC; Moertel CL; Heisel MA
    J Pediatr Hematol Oncol; 1997; 19(4):339-44. PubMed ID: 9256834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
    Quarello F; Forneris G; Borca M; Pozzato M
    J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central venous access devices for paediatric patients with haemophilia: a single-institution experience.
    Titapiwatanakun R; Moir C; Pruthi RK; Stavlo PL; Schmidt KA; Rodriguez V
    Haemophilia; 2009 Jan; 15(1):168-74. PubMed ID: 19149849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Encapsulated implantable venous access device: two clinical cases].
    Guivarch E; Kriegel I; Bonnet L; di Maria S; Estève M
    Ann Fr Anesth Reanim; 2009 Mar; 28(3):238-41. PubMed ID: 19327941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable subcutaneous venous access devices: is port fixation necessary? A review of 534 cases.
    McNulty NJ; Perrich KD; Silas AM; Linville RM; Forauer AR
    Cardiovasc Intervent Radiol; 2010 Aug; 33(4):751-5. PubMed ID: 19957181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insertion of an implantable venous access device in the groin using inferior epigastric vein.
    Singh SJ; Martin HC
    J Pediatr Surg; 2001 Apr; 36(4):579-81. PubMed ID: 11283881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of implantable venous access devices in children with severe hemophilia: benefits and burden.
    Van Dijk K; Van Der Bom JG; Bax KN; Van Der Zee DC; Van Den Berg MH
    Haematologica; 2004 Feb; 89(2):189-94. PubMed ID: 15003894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Totally implantable central venous access ports. Analysis of 700 cases.
    Barbetakis N; Asteriou C; Kleontas A; Tsilikas C
    J Surg Oncol; 2011 Nov; 104(6):654-6. PubMed ID: 21671465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complications of central venous and indwelling catheterization].
    Douard MC; Desruennes E; Kriegel I; Blot F
    Rev Prat; 2006 Jun; 56(12):1281-9. PubMed ID: 16948214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Implantable catheter systems. Experiences with 1000 patients with central venous ports].
    Kock HJ; Krause U; Pietsch M; Rasfeld S; Walz MK
    Dtsch Med Wochenschr; 1996 Jan; 121(3):47-51. PubMed ID: 8565809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience at a single institution with endovascular treatment of mechanical complications caused by implanted central venous access devices in pediatric and adult patients.
    Bessoud B; de Baere T; Kuoch V; Desruennes E; Cosset MF; Lassau N; Roche A
    AJR Am J Roentgenol; 2003 Feb; 180(2):527-32. PubMed ID: 12540466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.